Latest California Healthline Stories
Proposed PFAS Rule Would Cost Companies Estimated $1B; Lacks Limits and Cleanup Requirement
A proposed Environmental Protection Agency rule calls for companies to disclose PFAS manufactured or imported since 2011. The chemical industry is upset because such compliance would cost an estimated $1 billion, while environmental health advocates worry because the rule wouldn’t ban the chemicals outright.
Meet the People Deciding How to Spend $50 Billion in Opioid Settlement Cash
As settlement dollars land at the state level, state councils wield significant power in determining how the windfall gets spent. And, though they will likely include the most knowledgeable voices on addiction, these panels also face concerns about conflicts of interest and other issues.
What You Need to Know About the Drug Price Fight in Those TV Ads
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients.
Idaho Drops Panel Investigating Pregnancy-Related Deaths as US Maternal Mortality Surges
Amid a years-long rise in maternal mortality rates in the United States, Idaho lawmakers decided to disband a committee created to investigate pregnancy-related deaths.
‘It Was a Bloodbath’: Rare Dialysis Complication Can Kill, and More Could Be Done To Stop It
A venous needle dislodgment is a rare dialysis complication that can kill a patient in minutes. Some experts worry those who treat themselves at home are at increased risk.
Medi-Cal’s Fragmented System Can Make Moving a Nightmare
When Medi-Cal beneficiary Lloyd Tennison moved last year from Contra Costa County to San Joaquin County, he was bumped off his managed care plan without notice before his new coverage took effect. His case highlights a chronic issue in California’s fragmented Medicaid program.
Montana Adds Protections for Kids in Private Residential Treatment Programs
Programs in the so-called troubled teen industry will be required to provide a 24-hour hotline and unmonitored video calls with family and be subject to more inspections under a new Montana law.
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.
How Health Care May Be Affected by the High Court’s Affirmative Action Ruling
Some medical professionals warn that the Supreme Court’s recent ruling against using race as a factor in admissions could have far-reaching implications for the diversity of medical students, the practice of medicine, and patient care. Here’s what you need to know.
Cómo puede afectar a la atención médica el fallo de acción afirmativa de la Corte Suprema
La decisión dijo que es inconstitucional que los colegios y universidades usen la raza como un factor en la admisión de estudiantes.